期刊文献+

血浆D-二聚体测定在深静脉血栓形成中的意义 被引量:6

Measuring of D-dimer in patients with deep venous thrombosis
下载PDF
导出
摘要 目的:探讨血浆D-二聚体测定对深静脉血栓形成(DVT)诊断和疗效评估的意义及DVT患者临床危险因素。方法回顾性分析435例DVT患者的血浆D-二聚体水平,同时在体检人群中随机选择150例作为对照组,比较分析DVT患者中135例初诊时的危险因素。进一步监测其中的33例DVT患者治疗后1-3d、7-10d、15d的血浆D-二聚体变化情况。结果 DVT患者血浆D-二聚体水平与对照组相比有统计学差异(P=0.000),抗凝治疗的有效率为78.8%。治疗有效组DVT患者的血浆D-二聚体下降程度与无效组相比有统计学差异(P=0.005)。年龄<40岁的DVT患者中手术和外伤是主要危险因素,而年龄≥40岁患者中肿瘤、内科疾病、中心静脉置管及长期卧床是其主要危险因素。结论血浆D-二聚体是DVT诊断及疗效评估的重要指标,DVT危险因素是其一级预防的依据。 Objective To investigate plasma D- dimer levels in patients with deep venous thrombosis (DVT). Methods Plasma D- dimer levels were measured in 435 patients with DVT, and 150 healthy subjects (controls). The clinical data and plas-ma D- dimer levels were retrospectively analyzed in 135 DVT patients and the D- dimer levels were monitored in 33 DVT patients during the anticoagulation therapy at different time points (at 1-3d, 7-10d and 15d). Results Compared to healthy subjects, plasma D- dimer levels in DVT patients were significantly increased (P=0.000). The overal effective rate of treatment was 78.8%, D- dimer levels in effective patientws was significantly decreased after treatment (P=0.005). For patients aged〈40, surgery and trauma were major risk factors of DVT;for those aged≥40, medical diseases, cancer, placement of central venous catheter and long- term bed rest were major risk factors. Conclusion Measurement of plasma D- dimer levels is of value in diagnosis and monotoring of therapeutic effect for patients with deep vein thrombosis.
作者 徐颖 钱申贤
出处 《浙江医学》 CAS 2013年第22期1985-1988,共4页 Zhejiang Medical Journal
基金 杭州市科技局项目(20080333B09)
关键词 深静脉血栓形成D-二聚体 疗效 危险因素 Deep venous thrombosis D-dimer Curative effect Risk factor
  • 相关文献

参考文献16

  • 1Anderson F A Jr, Spencer F A. Risk Factors for Venous Throm- boembolism[J]. Circulation, 2003, 107(23):9-16.
  • 2White R H. The epidemiology of venous thromboembolism[J]. Circulation, 2003, 107(23): 14-18.
  • 3Ramagopalan S V, Wotton C J, Handel A E, et al. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study[J]. BMC Med, 2011, 10(9):1.
  • 4深静脉血栓形成的诊断和治疗指南(第二版)[J].中华普通外科杂志,2012,27(7):605-607. 被引量:161
  • 5van der Graaf F, van den Borne H, van der Kolk M, et al. Exclusion of deep venous thrombosis with D-dimer testing-comparison 13 D-dimer methords in 99 outpatients suspected of deep venous thrombosis using venography as reference standard[J]. Thromb Haemost, 2000, 83(2): 191 - 198.
  • 6王利新,景在平,包俊敏,赵志青,梅志军,王利丽.急性深静脉血栓溶栓治疗前后血清D-二聚体的变化[J].外科理论与实践,2005,10(1):80-82. 被引量:7
  • 7Lawler C M, Bovill E G, Stump D C, et al. Fibrin fragment D-dimer and fibrinogen B peptides in plasma as markers of clot lysis dur- ing thrombolytic therapy in acute myocardial infraction[J]. Blood, 1990,76(7): 1341 - 1348.
  • 8Cosmi B, Legnani C, Tosetto A, et al. Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study[J], J Thromb Thrombolysis, 2009, 28(4):381-388.
  • 9Verhovsek M, Douketis J D, Yi Q, et al. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therary for unprovoled venous thromboembolism[J]. Ann Intern Med, 2008, 149(7):484-490.
  • 10Samama M M,Cohen A T,Darmon J Y,et aL A comparison of enoxaparin with placebo for the prevention of venous throm- boembolism Ln acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group[J]. N Engl J Med, 1999, 341(11):793-800.

二级参考文献9

  • 1Siragusa S, Piovella F, Barone M, et al. Venous thromboembolism: epidemiology and risk factors[J]. Minerva Cardioangiol, 1996, 44(11): 581-589.
  • 2Janssen MC, Heebels AE, de Metz M, et al. Reliability of five rapid D-dimer assays compared to ELISA in the exclusion of deep venous thrombosis[J]. Thromb Haemost,1997, 77(2): 262-266.
  • 3Bounameaux H, de Moerloose P, Perrier A, et al.Ddimer testing in suspected venous thromboembolism:an update[J]. QJM, 1997, 90(7): 437-442.
  • 4White RH .The epidemiology of venous thromboembolism[J].Circulation, 2003, 107(23 suppl 1): I4-I8.
  • 5Dempfle CE. Use of D-dimer assays in the diagnosis of venous thrombosis[J]. Semin Thromb Hemost, 2000, 26(6): 631-641.
  • 6Greensberg CS, Dcvine DV, McCrae KM. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled latex beed [J].Am J Clin Pathol,1987, 87(1): 94-100.
  • 7Khaira HS, Mann J. Plasma D-dimer measurement in patients with suspected DVT-a means of avoiding unnec-essary venography[J]. Eur J Vasc Endovasc Surg, 1998,15(3): 235-238.
  • 8Hirsh J, Lee AY. How we diagnose and treat deep vein thrombosis[J]. Blood, 2002, 99(9): 3102-3110.
  • 9余静,骆雷鸣,余远琳.尿激酶治疗冠心病血浆D-二聚体的变化研究[J].临床心血管病杂志,1998,14(1):21-23. 被引量:22

共引文献166

同被引文献55

  • 1杨俊,王冠,吴晓芬,全小庆,阮磊,缪建平,袁俊强,张存泰.床旁联合检测NT-proBNP、cTnT、D-二聚体在心血管急症早期诊断中的价值[J].中国动脉硬化杂志,2015,23(1):64-68. 被引量:15
  • 2李朝明,郑琦.Wells评分和血浆D-二聚体检测在诊断骨折患者下肢深静脉血栓形成中的应用分析[J].中华危重症医学杂志,2013,6(1):41-43.
  • 3Wells E Overview and comparison of D- dimer assay kits for DVT and PE[J]. Clin Adv Hematol Oncol,2004,2(3):160-178.
  • 4Alexandra K. Thrombosis: Selective D-dimer testing improves efficiency of DVT diagnosis[J]. Nature reviews. Cardi- ology,2013,10(3):118-120.
  • 5Schouten H J, Koek HL, Oudega R, et al. Validation of two age dependent D-dimer cut-off values for exclusion of deep vein thrombosis in suspected elderly patients in primary care:retrospective, cross sectional, diagnostic analysis[J]. BMJ,2012,344(6): 2985-2987.
  • 6Hennig F, Fuks K, Moebus S, et al. Association between Source-Spe- cific Particulate Matter Air Pollution and hs-CRP: Local Traffic and Industrial Emissions [ J ]. Environmental Health Perspectives, 2014, 122(7) :703-710.
  • 7Das BK,Shyam A,Das R, et al. Simulation studies of the ion beam transport system in a compact electrostatic accelerator-based D-D neutron generator [ J ]. Nuclear Technology & Radiation Protection, 2014,29(4) :326-330.
  • 8Levin E, Serrano K, Devine DV. Standardization of CD62P measure- ment:results of an international comparative study. [ J]. Vox Sangui- nis ,2013,105 ( 1 ) :38-46.
  • 9Tominaga N, Hagiwara K, Kosaka N, et al. RPN2-mediated glycosyla- tion of tetraspanin CD63 regulates breast cancer cell malignancy[ J]. Molecular Cancer,2014,13 ( 1 ) : 1-11.
  • 10Azad N, Agrawal L, Emanuele NV, et al. Association of PAl-1 and Fi- brinogen With Diabetic Retinopathy in the Veterans Affairs Diabetes Trial (VADT) [ J ]. Diabetes Care,2013,37 ( 2 ) :501-506.

引证文献6

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部